HomeNAMS • NASDAQ
add
NewAmsterdam Pharma Company NV
Previous close
$21.44
Day range
$21.02 - $22.12
Year range
$5.63 - $26.35
Market cap
1.96B USD
Avg Volume
193.92K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.76M | 27.16% |
Operating expense | 50.66M | 59.24% |
Net income | -46.96M | -16.11% |
Net profit margin | -2.67K | 8.69% |
Earnings per share | — | — |
EBITDA | -48.90M | -60.70% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 340.45M | -27.21% |
Total assets | 347.10M | -27.46% |
Total liabilities | 58.70M | 21.21% |
Total equity | 288.39M | — |
Shares outstanding | 89.27M | — |
Price to book | 6.13 | — |
Return on assets | -35.22% | — |
Return on capital | -42.38% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -46.96M | -16.11% |
Cash from operations | -35.87M | -222.89% |
Cash from investing | -2.87M | -2,523.03% |
Cash from financing | 21.93K | -99.99% |
Net change in cash | -33.23M | -118.02% |
Free cash flow | -24.98M | -44.63% |
About
Founded
2019
Website
Employees
29